Archive: 06/23/2012
Declining testosterone levels in men not part of normal aging, study finds
A new study finds that a drop in testosterone levels over time is more likely to result from a man's behavioral and health changes than by aging. The study results will be presented Monday at The Endocrine Society's 94th ...
Health
Jun 23, 2012 |
4.7 / 5 (6) |
1
Hyperthyroidism linked to increased risk of hospitalization for heart and blood-vessel disease
An overactive thyroid gland, or hyperthyroidism, may increase the risk of hospitalization for heart and blood-vessel disease even after surgery to remove the gland, according to a new study. The results will be presented ...
Diseases, Conditions, Syndromes
Jun 23, 2012 |
not rated yet |
0
Low steroid levels linked to increased risk of cardiovascular disease
Low levels of a naturally occurring steroid are associated with an increased risk of heart and blood-vessel disease in elderly men, a new study finds. The results will be presented Saturday at The Endocrine Society's 94th ...
Cardiology
Jun 23, 2012 |
5 / 5 (2) |
0
Mild thyroid dysfunction in early pregnancy linked to serious complications
Even moderate thyroid dysfunction during early pregnancy significantly increases the risk of serious complications, underscoring the need for universal screening in the first trimester, a new study finds. The results will ...
Diseases, Conditions, Syndromes
Jun 23, 2012 |
not rated yet |
0
Long-term testosterone treatment for men results in reduced weight and waist size
In testosterone-deficient men, major weight loss was an added benefit of testosterone replacement therapy for most of the patients who participated in a new study. The results will be presented Saturday at The Endocrine Society's ...
Medical research
Jun 23, 2012 |
not rated yet |
0
No therapy for 20 percent with stage IV solid tumors
(HealthDay) -- About 20 percent of patients diagnosed with stage IV metastatic solid tumors do not receive anticancer treatment, according to a study published online June 15 in Cancer.
Cancer
Jun 23, 2012 |
5 / 5 (1) |
0
Predicting treatment response in central nervous system diseases
The commonly-used epilepsy drug, valproic acid (VPA), can have a highly beneficial effect on some babies born with spinal muscular atrophy (SMA), the number one genetic killer during early infancy. But in about two-thirds ...
Genetics
Jun 23, 2012 |
not rated yet |
0
- Pages: 1
